skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma

Abstract

A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.

Inventors:
;
Publication Date:
Research Org.:
LBNL (Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States))
Sponsoring Org.:
USDOE
OSTI Identifier:
1150642
Patent Number(s):
8,809291
Application Number:
13/252,148
Assignee:
California Pacific Medical Center Research Institute (San Francisco, CA); The Regents of the University of California (Oakland, CA) LBNL
DOE Contract Number:  
AC03-765F00098
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Desprez, Pierre-Yves, and Campisi, Judith. Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma. United States: N. p., 2014. Web.
Desprez, Pierre-Yves, & Campisi, Judith. Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma. United States.
Desprez, Pierre-Yves, and Campisi, Judith. Tue . "Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma". United States. doi:. https://www.osti.gov/servlets/purl/1150642.
@article{osti_1150642,
title = {Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma},
author = {Desprez, Pierre-Yves and Campisi, Judith},
abstractNote = {A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Aug 19 00:00:00 EDT 2014},
month = {Tue Aug 19 00:00:00 EDT 2014}
}

Patent:

Save / Share: